Cartesian Therapeutics
$9.27
77
+$0.15+1.64% Friday 20:00
+$0.00+0%Friday 23:30After hours
Statistics
Day High
9.3
Day Low
9.25
52W High
11
52W Low
5.6
Volume
4,717
Avg. Volume
-
Mkt Cap
280.47M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
5NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-1.46
-0.81
-0.15
0.5
Expected EPS
-1.008612
Actual EPS
N/A
Financials
-4,658.63%Profit Margin
Unprofitable2.8MRevenue
-130.3MNet Income
Analyst Ratings
36.75Average Price Target
The highest estimate is 44.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow RNAC. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Allogene Therapeutics
ALLO
Mkt Cap680.62M
CRISPR Therapeutics
CRSP
Mkt Cap5.39B
Novartis
NVS
Mkt Cap304.1B
Gilead Sciences
GILD
Mkt Cap187.23B
Pfizer
PFE
Mkt Cap162.16B
About
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Show more...
CEO
Carsten Brunn
Employees
75
Country
United States
ISIN
US8162123025
WKN
000A407YS
Listings
0 Comments
Share your thoughts
FAQ
What is Cartesian Therapeutics stock price today?▼
The current price of RNAC is $9.27 USD — it has increased by +1.64% in the past 24 hours. Watch Cartesian Therapeutics stock price performance more closely on the chart.
What is Cartesian Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Cartesian Therapeutics stocks are traded under the ticker RNAC.
Is Cartesian Therapeutics stock price growing?▼
RNAC stock has fallen by -0.11% compared to the previous week, the month change is a +4.75% rise, over the last year Cartesian Therapeutics has showed a -12.88% decrease.
What is Cartesian Therapeutics market cap?▼
Today Cartesian Therapeutics has the market capitalization of 280.47M
When is the next Cartesian Therapeutics earnings date?▼
Cartesian Therapeutics is going to release the next earnings report on November 05, 2026.
What were Cartesian Therapeutics earnings last quarter?▼
RNAC earnings for the last quarter are 0.46 USD per share, whereas the estimation was -0.88 USD resulting in a +152.4% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cartesian Therapeutics revenue for the last year?▼
Cartesian Therapeutics revenue for the last year amounts to 2.8M USD.
What is Cartesian Therapeutics net income for the last year?▼
RNAC net income for the last year is -130.3M USD.
How many employees does Cartesian Therapeutics have?▼
As of September 07, 2026, the company has 75 employees.
In which sector is Cartesian Therapeutics located?▼
Cartesian Therapeutics operates in the Health & Wellness sector.
When did Cartesian Therapeutics complete a stock split?▼
The last stock split for Cartesian Therapeutics was on April 05, 2024 with a ratio of 1:30.
Where is Cartesian Therapeutics headquartered?▼
Cartesian Therapeutics is headquartered in FREDERICK, United States.